Drugs / RRR-alpha-tocopherol
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00419146 | Sep 2001 → Apr 2004 | schizoaffective disorder, schizophrenia, schizophreniform disorder | University Hospital, Aker | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00281307 | Dec 2005 → Sep 2007 | rhinitis | Milton S. Hershey Medical Center | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RRR-alpha-tocopherol | “RRR-alpha-tocopherol 392 mg + slow-release ascorbic acid 1000 mg per day, for 16 weeks” NCT00419146 ↗ |
| Route | Intranasal | “applied intranasally to the mucosa” NCT00281307 ↗ |